Literature DB >> 15716360

Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis.

Philip Seeman1, David Weinshenker, Remi Quirion, Lalit K Srivastava, Sanjeev K Bhardwaj, David K Grandy, Richard T Premont, Tatyana D Sotnikova, Patricia Boksa, Mufida El-Ghundi, Brian F O'dowd, Susan R George, Melissa L Perreault, Pekka T Männistö, Siobhan Robinson, Richard D Palmiter, Teresa Tallerico.   

Abstract

Dopamine supersensitivity occurs in schizophrenia and other psychoses, and after hippocampal lesions, antipsychotics, ethanol, amphetamine, phencyclidine, gene knockouts of Dbh (dopamine beta-hydroxylase), Drd4 receptors, Gprk6 (G protein-coupled receptor kinase 6), Comt (catechol-O-methyltransferase), or Th-/-, DbhTh/+ (tyrosine hydroxylase), and in rats born by Cesarean-section. The functional state of D2, or the high-affinity state for dopamine (D2High), was measured in these supersensitive animal brain striata. Increased levels and higher proportions (40-900%) for D2High were found in all these tissues. If many types of brain impairment cause dopamine behavioral supersensitivity and a common increase in D2High states, it suggests that there are many pathways to psychosis, any one of which can be disrupted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716360      PMCID: PMC548961          DOI: 10.1073/pnas.0409766102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.

Authors:  Raul R Gainetdinov; Laura M Bohn; Tatyana D Sotnikova; Michel Cyr; Aki Laakso; Alexander D Macrae; Gonzalo E Torres; Kyeong Man Kim; Robert J Lefkowitz; Marc G Caron; Richard T Premont
Journal:  Neuron       Date:  2003-04-24       Impact factor: 17.173

2.  Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy.

Authors:  Shitij Kapur; Susan C VanderSpek; Barbara A Brownlee; Jose N Nobrega
Journal:  J Pharmacol Exp Ther       Date:  2003-02-20       Impact factor: 4.030

3.  Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control.

Authors:  H Szechtman; M J Eckert; W S Tse; J T Boersma; C A Bonura; J Z McClelland; K E Culver; D Eilam
Journal:  BMC Neurosci       Date:  2001-04-12       Impact factor: 3.288

4.  Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals.

Authors:  David Weinshenker; Nicole S Miller; Katherine Blizinsky; Marc L Laughlin; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

5.  Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.

Authors:  Philip Seeman; Teresa Tallerico; Françoise Ko; Catherine Tenn; Shitij Kapur
Journal:  Synapse       Date:  2002-12-15       Impact factor: 2.562

6.  Dopamine-deficient mice are hypersensitive to dopamine receptor agonists.

Authors:  D S Kim; M S Szczypka; R D Palmiter
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

7.  Prolonged fear responses in mice lacking dopamine D1 receptor.

Authors:  M El-Ghundi; B F O'Dowd; S R George
Journal:  Brain Res       Date:  2001-02-16       Impact factor: 3.252

Review 8.  Atypical antipsychotics: mechanism of action.

Authors:  Philip Seeman
Journal:  Can J Psychiatry       Date:  2002-02       Impact factor: 4.356

9.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior.

Authors:  J A Gogos; M Morgan; V Luine; M Santha; S Ogawa; D Pfaff; M Karayiorgou
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Dopamine D1 receptor changes due to caesarean section birth: effects of anesthesia, developmental time course, and functional consequences.

Authors:  Patricia Boksa; Ying Zhang; Alain Bestawros
Journal:  Exp Neurol       Date:  2002-06       Impact factor: 5.330

View more
  92 in total

Review 1.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

Review 2.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

3.  Differential effects of acute and chronic treatment with the α2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys.

Authors:  Stephen J Kohut; Peter A Fivel; Nancy K Mello
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

4.  Dopamine beta-hydroxylase-deficient mice have normal densities of D(2) dopamine receptors in the high-affinity state based on in vivo PET imaging and in vitro radioligand binding.

Authors:  Mette Skinbjerg; Nicholas Seneca; Jeih-San Liow; Jinsoo Hong; David Weinshenker; Victor W Pike; Christer Halldin; David R Sibley; Robert B Innis
Journal:  Synapse       Date:  2010-09       Impact factor: 2.562

5.  Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2(High) receptors.

Authors:  Sanders A McDougall; Joseph M Valentine; Ashley E Gonzalez; Danielle E Humphrey; Crystal B Widarma; Cynthia A Crawford
Journal:  Psychopharmacology (Berl)       Date:  2013-11-28       Impact factor: 4.530

Review 6.  What is the mechanism whereby cannabis use increases risk of psychosis?

Authors:  Sonija Luzi; Paul D Morrison; John Powell; Marta di Forti; Robin M Murray
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

7.  Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats.

Authors:  Fausto A Varela; Taleen Der-Ghazarian; Ryan J Lee; Sergios Charntikov; Cynthia A Crawford; Sanders A McDougall
Journal:  J Psychopharmacol       Date:  2013-09-17       Impact factor: 4.153

8.  Dopamine D1 receptor antagonist reduces stimulant-induced conditioned place preferences and dopamine receptor supersensitivity.

Authors:  Sun Mi Gu; Hye Jin Cha; So Woon Seo; Jin Tae Hong; Jaesuk Yun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-01       Impact factor: 3.000

9.  Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: reproducibility in tracer characteristics and characterization of extrastriatal binding.

Authors:  Alice Egerton; Ella Hirani; Rabia Ahmad; David R Turton; Diana Brickute; Lula Rosso; Oliver D Howes; Sajinder K Luthra; Paul M Grasby
Journal:  Synapse       Date:  2010-04       Impact factor: 2.562

10.  Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.

Authors:  Kathryn M Gill; James M Cook; Michael M Poe; Anthony A Grace
Journal:  Schizophr Bull       Date:  2014-01-24       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.